First-in-Human Clinical Trial to Assess Gene Therapy for Alzheimer’s Disease

This shows the outline of a head and a question markResearchers launch the first-in-human phase 1 clinical trial to assess the safety and efficacy of a gene therapy which will deliver BDNF to the brains of those with Alzheimer’s and mild cognitive impairment.